Peter Capell

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Laurie L. Carr, David A. Mankoff, Bernardo Goulart et al. · Clinical Cancer Research · 2010 · 418 citations · Full text

Medicine, Oncology, Pharmacology +17

The Effect of Short-Term Testosterone Administration on Serum FSH, LH and Testosterone Levels: Evidence for Selective Abnormality in LH Control in Patients with Klinefelter's Syndrome

Peter Capell, C. Alvin Paulsen, DAVID DERLETH et al. · The Journal of Clinical Endocrinology & Metabolism · 1973 · 62 citations

Medicine, Endocrinology, Andrology +16

Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC)

Bernardo Goulart, Laurie Carr, R. G. Martins et al. · Journal of Clinical Oncology · 2008 · 32 citations

Medicine, Oncology, Pharmacology +17

The effect of exogenous testosterone upon serum FSH and LH concentrations in normal males

Peter Capell, C. Alvin Paulsen · Contraception · 1972 · 23 citations

Medicine, Endocrinology, Andrology +14

Phase II trial of continuous dosing of sunitinib in advanced, FDG-PET avid, medullary thyroid carcinoma (MTC) and well-differentiated thyroid cancer (WDTC)

Laurie Carr, Bernardo Goulart, Renato Martins et al. · Journal of Clinical Oncology · 2009 · 21 citations

Medicine, Oncology, Pharmacology +16